id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-262193-p7foay4k	Ahmad, I.	Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities	2020-05-22		.txt	text/plain	2468	157	55	title: Doxycycline and Hydroxychloroquine as Treatment for High-Risk COVID-19 Patients: Experience from Case Series of 54 Patients in Long-Term Care Facilities The effectiveness of doxycycline (DOXY) and hydroxychloroquine (HCQ) combination therapy in high risk COVID-19 patients in long-term care facilities is not yet understood. Results: A series of fifty-four (54) high-risk patients, who developed a sudden onset of fever, cough, and shortness of breath (SOB) and were diagnosed or presumed to have COVID-19, were started with a combination of DOXY-HCQ and 85% (n=46) patients showed clinical recovery defined as: resolution of fever and SOB, or a return to baseline setting if patients are ventilator-dependent. From March 19 to March 30, 2020, we analyzed the clinical outcomes of fifty-four (54) high-risk patients who developed a sudden onset of fever, cough, and SOB, were diagnosed or presumed to have COVID-19, and were treated with DOXY (100 mg PO BID for 7 days) and HCQ (two regimens: i) 200 mg PO TID for 7 days or ii) 400 mg PO BID one day, then 400 mg daily for 6 days).	./cache/cord-262193-p7foay4k.txt	./txt/cord-262193-p7foay4k.txt